Dengue and chikungunya 2016

drashokrattan 4,051 views 48 slides Sep 14, 2016
Slide 1
Slide 1 of 48
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24
Slide 25
25
Slide 26
26
Slide 27
27
Slide 28
28
Slide 29
29
Slide 30
30
Slide 31
31
Slide 32
32
Slide 33
33
Slide 34
34
Slide 35
35
Slide 36
36
Slide 37
37
Slide 38
38
Slide 39
39
Slide 40
40
Slide 41
41
Slide 42
42
Slide 43
43
Slide 44
44
Slide 45
45
Slide 46
46
Slide 47
47
Slide 48
48

About This Presentation

how to diagnose and manage dengue and chikungunya


Slide Content

Dengue & Chikungunya Viral infections Arbo Viral Infections RNA viruses Prof. Ashok Rattan, MD, MAMS, INSA DFG, WHO Lab Director Academics, Industry: Research, Diagnosis, Public Health, Academics

Dengue Of great antiquity, clinically known in China Swahili “ ka dinga pepo ” Along with slaves ; Africa  Caribbean In Cuba (Spanish) Dinga is Dengue (fastidious) 4 closely related RNA viruses DEN 1, DEN 2, DEN 3, DEN 4 Share same geographical & ecological niche Ss RNA, flavi virus

Dengue Virus

Mosquito Transmission: Aedes aegypti and Aedes albopictus

Transmission: Aedes mosquito Aedes aegypti Urban mosquito Needs standing water for larvae Prefers cool, dark areas for resting Feeds through the day, most active at dawn/dusk Eggs do not survive winter in temperate climates Aedes albopictus : Asian Tiger Mosquito Urban, periurban , rural habitats Feeds through the day, most active dawn/afternoon Eggs survive winter in temperate climates Invasive- spreading in Europe and Americas www.cdc.gov

Course of Dengue illness

Lumsden WH. Trans Roy Soc Trop Med Hyg 1955;49:33-57

Chikungunya Virus (CHIKV): Alphavirus “ That which bends up ” in Swahili Togaviridae family Single strand RNA virus, mosquito-transmitted www.cdc.gov/ncidod/dvbid/arbor/alphavir.htm

20 What is Chikungunya? Chikungunya is a virus that is transmitted from human to human mainly by infected Aedes albopictus and Aedes aegypti mosquitoes acting as the disease-carrying vector Chikungunya causes sudden onset of high fever, severe joint pain, muscle pain and headache 3 main presentations Acute: sudden onset, Severe, incapacitating polyarthralgia Maculopapular rash on trunk & extremities Subacute : Relapse of symptoms 2 to 3 months following initial infection Exacerbated pain in previously affected joints Chronic: Persistence of arthralgia & fatigue for > 3 months Prevalence in 12 to 50%

21 Symptoms Symptoms include: Sudden onset of high fever Headache Back pain Myalgia Arthralgia The symptoms will appear on average 4 to 7 days (but can range from 1 to 12 days) after being bitten by an infected Aedes mosquito

Mosquito Transmission: Aedes aegypti and Aedes albopictus

Transmission: Aedes mosquito Aedes aegypti Urban mosquito Needs standing water for larvae Prefers cool, dark areas for resting Feeds through the day, most active at dawn/dusk Eggs do not survive winter in temperate climates Aedes albopictus : Asian Tiger Mosquito Urban, periurban , rural habitats Feeds through the day, most active dawn/afternoon Eggs survive winter in temperate climates Invasive- spreading in Europe and Americas www.cdc.gov

24 Epidemiology Chikungunya risk zones Outbreaks of Chikungunya virus are usually found in: Africa Southeast Asia Indian subcontinent and islands in the Indian Ocean

CHIKV: re-emerging disease Initial descriptions in 1950s 2000 Epidemic in Kinshasa, DRC, 1 st in 39 years 2001-2003 epidemic in Indonesia, 1 st in 20 years 2004 Coastal Kenya E226V mutation more efficiently transmitted by Aedes albopictus 2005 Spread to Comoros Islands 2005-2007 Epidemic in Réunion: 35% attack rate 266,000 cases 0.1% mortality 2006 Maldives & India 2008 Singapore 2012 Rural Cambodia 44.7% prevalence 5.3% asymptomatic 2012 Bhutan 1 st cases reported Index case recent travel from India East/Central/South African genotype 2012 Papua New Guinea 1 st cases reported MMWR 2012; 61: 737-40 www.cdc.gov/eid 2013 vol 19

Treatment and Prevention Acute Illness Supportive care NSAIDS Case reports of short steroid courses for severe early disease Persistent arthralgias : no good data for treatment Chloroquine , hydroxychloroquine No sig difference in efficacy for acute arthralgias between chloroquine and meloxicam in 509 indiv in India Sulfasalazine, methotrexate, ribavirin, interferon-alpha Mosquito avoidance Vaccines in research, not licensed Monoclonal antibodies as prophylaxis effective in mouse models

Incubation Period

42 What should I do if I suspect my patient has Chikungunya ? Chikungunya is a reportable disease. ECDC proposes the following reporting levels: Case categories Possible case : a patient meeting clinical criteria Probable case : a patient meeting both the clinical and epidemiological criteria Confirmed case : a patient meeting the laboratory criteria, irrespective of the clinical presentation

43 Algorithm for ascertainment of suspected Chikungunya case Source : ECDC Mission Report: Chikungunya in Italy, Joint ECDC/WHO visit for a European risk assessment 17 – 21 September 2007

Protection Personal protection: DEET, Picaridin Household prevention: Screen, Bed nets Neighbourhood & community prevention Vector Control Same as for Dengue vector control